Insider Brief Imperagen has raised £5 million in seed funding to expand its enzyme engineering platform driven by quantum physics and artificial intelligence. The funding was led by PXN Ventures, with participation from existing investors IQ Capital and Northern Gritstonebrings, bringing the company’s total capital raised to £8.5 million, according to the company. Imperagen said […]

Source: The Quantum Insider — read the full report at the original publisher.

This is a curated wire item. The Continuum Brief does not republish full third-party articles; this entry links to the original source.